189 related articles for article (PubMed ID: 29300353)
1. Computational Insights into the Interactions between Calmodulin and the c/nSH2 Domains of p85α Regulatory Subunit of PI3Kα: Implication for PI3Kα Activation by Calmodulin.
Ni D; Liu D; Zhang J; Lu S
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29300353
[TBL] [Abstract][Full Text] [Related]
2. Calmodulin (CaM) Activates PI3Kα by Targeting the "Soft" CaM-Binding Motifs in Both the nSH2 and cSH2 Domains of p85α.
Zhang M; Li Z; Wang G; Jang H; Sacks DB; Zhang J; Gaponenko V; Nussinov R
J Phys Chem B; 2018 Dec; 122(49):11137-11146. PubMed ID: 30047727
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated Calmodulin Promotes PI3K Activation by Binding to the SH
Zhang M; Jang H; Gaponenko V; Nussinov R
Biophys J; 2017 Nov; 113(9):1956-1967. PubMed ID: 29117520
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Calmodulin with the cSH2 Domain of the p85 Regulatory Subunit.
Wang G; Zhang M; Jang H; Lu S; Lin S; Chen G; Nussinov R; Zhang J; Gaponenko V
Biochemistry; 2018 Mar; 57(12):1917-1928. PubMed ID: 29494137
[TBL] [Abstract][Full Text] [Related]
5. Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction.
Jang H; Banerjee A; Chavan T; Gaponenko V; Nussinov R
J Biol Chem; 2017 Jul; 292(30):12544-12559. PubMed ID: 28623230
[TBL] [Abstract][Full Text] [Related]
6. Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B.
Li X; Dai J; Ni D; He X; Zhang H; Zhang J; Fu Q; Liu Y; Lu S
Int J Biol Macromol; 2020 Feb; 144():643-655. PubMed ID: 31816384
[TBL] [Abstract][Full Text] [Related]
7. Calmodulin and IQGAP1 activation of PI3Kα and Akt in KRAS, HRAS and NRAS-driven cancers.
Nussinov R; Zhang M; Tsai CJ; Jang H
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2304-2314. PubMed ID: 29097261
[TBL] [Abstract][Full Text] [Related]
8. K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?
Nussinov R; Muratcioglu S; Tsai CJ; Jang H; Gursoy A; Keskin O
Expert Opin Ther Targets; 2016 Jul; 20(7):831-42. PubMed ID: 26873344
[TBL] [Abstract][Full Text] [Related]
9. The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas.
Nussinov R; Muratcioglu S; Tsai CJ; Jang H; Gursoy A; Keskin O
Mol Cancer Res; 2015 Sep; 13(9):1265-73. PubMed ID: 26085527
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin and PI3K Signaling in
Nussinov R; Wang G; Tsai CJ; Jang H; Lu S; Banerjee A; Zhang J; Gaponenko V
Trends Cancer; 2017 Mar; 3(3):214-224. PubMed ID: 28462395
[TBL] [Abstract][Full Text] [Related]
11. Structure, dynamics and interaction with kinase targets: computer simulations of calmodulin.
Yang C; Jas GS; Kuczera K
Biochim Biophys Acta; 2004 Mar; 1697(1-2):289-300. PubMed ID: 15023369
[TBL] [Abstract][Full Text] [Related]
12. Regulation of K-Ras4B Membrane Binding by Calmodulin.
Sperlich B; Kapoor S; Waldmann H; Winter R; Weise K
Biophys J; 2016 Jul; 111(1):113-22. PubMed ID: 27410739
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase α.
Echeverria I; Liu Y; Gabelli SB; Amzel LM
FEBS J; 2015 Sep; 282(18):3528-42. PubMed ID: 26122737
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics studies on conformational thermodynamics of Orai1-calmodulin complex.
Maganti L; Ghosh M; Chakrabarti J
J Biomol Struct Dyn; 2018 Oct; 36(13):3411-3419. PubMed ID: 28978262
[TBL] [Abstract][Full Text] [Related]
15. Insights into molecular interactions between CaM and its inhibitors from molecular dynamics simulations and experimental data.
González-Andrade M; Rodríguez-Sotres R; Madariaga-Mazón A; Rivera-Chávez J; Mata R; Sosa-Peinado A; Del Pozo-Yauner L; Arias-Olguín II
J Biomol Struct Dyn; 2016; 34(1):78-91. PubMed ID: 25702612
[TBL] [Abstract][Full Text] [Related]
16. Investigating the disorder-order transition of calmodulin binding domain upon binding calmodulin using molecular dynamics simulation.
Zhang Y; Tan H; Chen G; Jia Z
J Mol Recognit; 2010; 23(4):360-8. PubMed ID: 19998355
[TBL] [Abstract][Full Text] [Related]
17. Allosteric Activation of PI3Kα Results in Dynamic Access to Catalytically Competent Conformations.
Chakrabarti M; Gabelli SB; Amzel LM
Structure; 2020 Apr; 28(4):465-474.e5. PubMed ID: 32049032
[TBL] [Abstract][Full Text] [Related]
18. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain.
Hofmann BT; Jücker M
Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814
[TBL] [Abstract][Full Text] [Related]
19. The structural basis of Akt PH domain interaction with calmodulin.
Weako J; Jang H; Keskin O; Nussinov R; Gursoy A
Biophys J; 2021 May; 120(10):1994-2008. PubMed ID: 33775637
[TBL] [Abstract][Full Text] [Related]
20. The Structural Basis of the Farnesylated and Methylated KRas4B Interaction with Calmodulin.
Jang H; Banerjee A; Marcus K; Makowski L; Mattos C; Gaponenko V; Nussinov R
Structure; 2019 Nov; 27(11):1647-1659.e4. PubMed ID: 31495533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
